ARA 014418
Alternative Names: AR-A014418; GSK-3beta inhibitor VIII AR-A014418; GSK-3β Inhibitor VIIILatest Information Update: 23 Aug 2017
At a glance
- Originator AstraZeneca
- Class Antidementias
- Mechanism of Action Glycogen synthase kinase 3 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Major depressive disorder
Most Recent Events
- 16 Jul 2017 Pharmacodynamics data from a preclinical trial in Alzheimer's disease presented at the Alzheimer's Association International Conference 2017 (AAIC-2017)
- 05 Feb 2008 Discontinued - Preclinical for Alzheimer's disease in Sweden (unspecified route)
- 05 Feb 2008 Discontinued - Preclinical for Depression in Sweden (unspecified route)